Noridian coverage updates include November tendon-injection conformity revisions
Oct 11, 2026 edition · GC-2026-0119 · Published 2026-10-11 · Version 3 · Final
Noridian pairs November 1 tendon-injection coverage and coding revisions. Its October 8 notices describe administrative conformity to the established chronic-pain nerve-procedure policy, rather than blanket injection coverage.
What happened
The published November 1 revisions pair L34218 revision 7 with A57079 revision 6 and describe administrative conformity to the chronic-pain peripheral-nerve policy L40265. The tendon/ligament/ganglion LCD addresses injections used within an overall treatment plan. Symptoms should resolve or be reevaluated after one to three injections; more than three injections at the same local site within six months require clinical justification for prior failure and an expectation of further benefit. The policy also questions repeated injections or more than two sites per session and excludes the described dry-needling procedures.
The companion billing guidance requires records supporting the diagnosis and decision to inject, additional justification for repeat treatment, and compliance with applicable correct-coding edits. Insufficient supporting documentation can lead to a medical-necessity denial. November 1 remains the future revision date as of October 11; these published documents should not be represented as already replacing the October version. Clinical justification and coding review remain separate from simply loading a revised article number. The public extract does not establish that every license-gated code table or individual claim satisfies the policy.
Scope and timing
- Authority status
- Final
- Applicability
- Directly applicable
- Audience
- Health systems, Provider networks
- Jurisdiction
- Federal, California
- Affected functions
- Coding, Revenue Cycle, Utilization Management, Clinical Operations, Compliance
- Responsible owner
- Coding
- Recorded date
- 2026-11-01
- Date type
- implementation
Why it matters
These are administrative conformity revisions under the listed JE Part B contractors, including California. The notices do not create blanket coverage for injections. The four earlier nerve-procedure and molecular-diagnostic updates remain a separate carryover research checkpoint pending current verification.
Recommended action
Compare tendon-injection criteria and coding edits with the operative LCD and article before November 1; separately recheck the four prior notices. Playbook dates are recommended internal targets.
Implementation playbook
- Compare L34218 and A57079 conformity changes with operative L40265 criteria. Coding · Due 2026-10-18
- Recheck prior notices and test affected service-line documentation and edits. Utilization Management · Due 2026-10-25
- Verify claim configuration before the November effective date. Revenue Cycle · Due 2026-10-30
Sources
- Noridian JE Latest UpdatesOfficial · Noridian Healthcare Solutions · 2026-09-17 · Source review 2026-09-20
- Injections, Tendon, Ligament and Ganglion Cyst (L34218), R7Official · Noridian · 2026-10-08 · Source review 2026-10-11
- Billing and Coding, Injections, Tendon, Ligament and Ganglion Cyst (A57079), R6Official · Noridian · 2026-10-08 · Source review 2026-10-11
- LCD L34218, published November 1, 2026 revision 7Official · CMS Medicare Coverage Database / Noridian · Source review 2026-10-14
- Billing and coding A57079, published November 1, 2026 revision 6Official · CMS Medicare Coverage Database / Noridian · Source review 2026-10-14
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Medicare & Medicaid report →